NEW YORK (GenomeWeb) – Quanterix this week named PBL Assay Science a preferred partner for assay research and development. 

Leveraging Quanterix's Simoa — a single-molecule array immunoassay technology for detecting and quantifying antigens and proteins — PBL will be able to enter new markets and strengthen its current product offerings, Quanterix said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.